OrphanDrug
OrphanDrug
Pharma Knowledge Base

hypertrophic cardiomyopathy 4

MeSH: C566169ORPHA: 155

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

hypertrophic cardiomyopathy that has material basis in heterozygous, homozygous, or compound heterozygous mutation in the gene encoding cardiac myosin-binding protein C (MYBPC3) on chromosome 11p11

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

MeSH Code

C566169

Orphanet Code

ORPHA:155
hypertrophic cardiomyopathy 4
MeSHC566169
OrphanetORPHA:155
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO